Latest news
Galaxy Therapeutics Achieves CE Mark for SEAL™ Embolization System, Enabling Commercial Launch Across Europe and International Markets - streetinsider.comstreetinsider.com · Tue, 04 Aug 2026 11:06:12 GMTCereVasc Opens New Massachusetts Facility in Preparation for eShunt® System Commercialization - PR NewswirePR Newswire · Thu, 30 Jul 2026 07:00:00 GMT